Short answer · Medically reviewed summary · Last updated: 2026-05-08
There is no single curative treatment for 1p36 Deletion Syndrome; instead, management focuses on multidisciplinary supportive care tailored to the specific developmental, neurological, and physical needs of the individual. Treatment plans typically involve early intervention therapies, management of epilepsy, and addressing specific congenital anomalies through surgical or medical interventions. What are the first-line treatments for 1p36 Deletion Syndrome? Management for 1p36 Deletion Syndrome is entirely symptomatic and supportive.
There is no single curative treatment for 1p36 Deletion Syndrome; instead, management focuses on multidisciplinary supportive care tailored to the specific developmental, neurological, and physical needs of the individual. Treatment plans typically involve early intervention therapies, management of epilepsy, and addressing specific congenital anomalies through surgical or medical interventions.
Management for 1p36 Deletion Syndrome is entirely symptomatic and supportive. Because the genetic deletion affects various systems, care is coordinated through a multidisciplinary team. First-line medical interventions prioritize the management of seizures, which occur in approximately 50-75% of patients with 1p36 Deletion Syndrome, and the correction of structural heart defects, which are present in about 70% of cases.
Early intervention is critical for individuals living with 1p36 Deletion Syndrome to maximize developmental potential. Common therapies include:
A coordinated care team is essential for 1p36 Deletion Syndrome. This team typically includes a clinical geneticist, a pediatric neurologist for seizure management, a cardiologist for structural heart monitoring, and an ophthalmologist. Because every patient experiences 1p36 Deletion Syndrome differently, the intensity and focus of these specialists must be personalized based on the patient's unique clinical profile.
Currently, there are no gene-based therapies for 1p36 Deletion Syndrome. Research is primarily focused on understanding the genotype-phenotype correlations to better predict clinical outcomes. Families are encouraged to consult their medical team regarding local clinical trials or registries that may track natural history, which provides vital data for future therapeutic development.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with your healthcare team to develop a personalized treatment plan for 1p36 Deletion Syndrome.